NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
The trial will include patients with so called "fusion-driven", metastatic
sarcomas of the following types:
- Ewing sarcoma,
- alveolar rhabdomyosarcoma
- or synovial sarcoma
who are in first or second complete remission or partial response
1 total trials1 recruiting
Filter these 1 trials by phase, country, sponsor and more.